On May 21, 2025, ClearPoint Neuro, Inc. held its annual stockholders meeting where shareholders approved several items including the Sixth Amended and Restated 2013 Incentive Compensation Plan and the 2021 Employee Stock Purchase Plan, among others. The directors elected for a term until 2026 received significant votes of approval, with notable votes such as 9,980,965 for director Joseph M. Burnett.